Gene · 57016
Papers1,760
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,760
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease. | Front Endocrinol (Lausanne) | 2022 | 36518239 | PubTator, text mining | PubMed |
| IL-17A and TNF-α inhibitors induce multiple molecular changes in psoriasis. | Front Immunol | 2022 | 36483564 | PubTator, text mining | PubMed |
| METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10. | Cancer Cell Int | 2022 | 36476503 | PubTator, text mining | PubMed |
| Non-alcoholic fatty liver disease and liver secretome. | Arch Pharm Res | 2022 | 36441472 | PubTator, text mining | PubMed |
| Microfluidic vascular models of tumor cell extravasation. | Front Oncol | 2022 | 36439519 | PubTator, text mining | PubMed |
| A Concise Review on Dysregulation of LINC00665 in Cancers. | Cells | 2022 | 36429005 | PubTator, text mining | PubMed |
| A pilot reverse virtual screening study suggests toxic exposures caused long-term epigenetic changes in Gulf War Illness. | Comput Struct Biotechnol J | 2022 | 36420170 | PubTator, text mining | PubMed |
| Identification of Glucose Metabolism-Related Genes in the Progression from Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma. | Genet Res (Camb) | 2022 | 36407083 | PubTator, text mining | PubMed |
| Exploring the mechanisms underlying the therapeutic effect of the Radix Bupleuri-Rhizoma Cyperi herb pair on hepatocellular carcinoma using multilevel data integration and molecular docking. | Aging (Albany NY) | 2022 | 36403263 | PubTator, text mining | PubMed |
| Role of Human Aldo-Keto Reductases in the Nitroreduction of 1-Nitropyrene and 1,8-Dinitropyrene. | Chem Res Toxicol | 2022 | 36399404 | PubTator, text mining | PubMed |
| Identification of the circRNA-miRNA-mRNA Regulatory Network in Pterygium-Associated Conjunctival Epithelium. | Biomed Res Int | 2022 | 36398070 | PubTator, text mining | PubMed |
| The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials. | Front Nutr | 2022 | 36386939 | PubTator, text mining | PubMed |
| F-actin architecture determines constraints on myosin thick filament motion. | Nat Commun | 2022 | 36385016 | PubTator, text mining | PubMed |
| Evaluating the Resources and Environmental Carrying Capacity in Laos Using a Three-Dimensional Tetrahedron Model. | Int J Environ Res Public Health | 2022 | 36360696 | PubTator, text mining | PubMed |
| Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD. | Antioxidants (Basel) | 2022 | 36358589 | PubTator, text mining | PubMed |
| The potential effects and mechanisms of Gegen Qinlian Decoction in oxaliplatin-resistant colorectal cancer based on network pharmacology. | Heliyon | 2022 | 36353164 | PubTator, text mining | PubMed |
| Nanotechnology strategies for hepatocellular carcinoma diagnosis and treatment. | RSC Adv | 2022 | 36349046 | PubTator, text mining | PubMed |
| Case report: Ultrasonographic findings of retroperitoneum and abdominal wall metastases of renal cell carcinoma with FH gene deletion. | Front Oncol | 2022 | 36330469 | PubTator, text mining | PubMed |
| Advances in the Diagnosis, Monitoring, and Progression of Oral Cancer through Saliva: An Update. | Biomed Res Int | 2022 | 36330456 | PubTator, text mining | PubMed |
| Integration analysis identifies the role of metallothionein in the progression from hepatic steatosis to steatohepatitis. | Front Endocrinol (Lausanne) | 2022 | 36329886 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57016/papers?page=18